Viral Vectors and Plasmid DNA Manufacturing Market to Reach $34.0 billion by 2033 at 20.4% CAGR: Allied Market Research
PR Newswire —
Increase in funding for R&D activities, surge in awareness regarding gene therapy, and rise in prevalence of cancer, viral infections, and genetic disorders drive the growth of global viral vectors and plasmid DNA manufacturing market PORTLAND, Ore., Feb. 23, 2026 /PRNewswire/ -- Allied...